Peyton completed her PhD in biomedical informatics and as a Schmidt Science Fellow, she worked on applying machine learning techniques to experimental design.

Scientists can now detect signs of cancer in blood samples through looking for pieces of mutated tumor DNA. Peyton worked to design primers that can detect tens of thousands of possible mutations quickly and cheaply in a blood sample. Frequently such primers are tested in a trial and error approach, which can be time-consuming, wasteful, and often ineffective.

Peyton worked to develop machine learning methods that optimize the design of primers and synthetic DNA sequences as efficiently as possible. These algorithms can then predict which experiments would be most effective for a scientist to perform next.

Peyton worked with Prof Emma Brunskill at Stanford as a Schmidt Science Fellow.

She is the Co-Founder and CSO of BigHat Biosciences.